Literature DB >> 7622623

Phagocytosis of apoptotic bodies by liver endothelial cells.

L Dini1, A Lentini, G D Diez, M Rocha, L Falasca, L Serafino, F Vidal-Vanaclocha.   

Abstract

Using electron microscopy and cytofluorimetry we studied the role of carbohydrate-specific recognition systems in the interaction of apoptotic bodies with normal and interleukin 1-activated sinusoidal endothelial cells. Microfluorimetric observation of liver tissue sections revealed octadecylrhodamine B-labelled apoptotic body binding to the sinusoidal wall of mouse liver, when they were injected intraportally. Plate-scanning cytofluorimetry demonstrated that about 20-25% of Acridine Orange-labelled apoptotic bodies could adhere specifically to cultured endothelial cells after 15 minutes of incubation. Adhesion increased to 30% when the cells were incubated for 60 minutes. Using a mixture of galactose/N-acetylglucosamine/mannose as competition solution apoptotic body adhesion was significantly reduced especially after longer times of incubation, when the percentage of inhibition reached 50%. Following 4 hours exposure of liver endothelial cells to 1 ng/ml human recombinant interleukin-1 beta adhesion markedly increased after 60 minutes of incubation, whereas the co-incubation of interleukin-1 beta with the inhibitors brings down the adhesion to basal values obtained in controls. Electron microscopic observation of the adhesion process showed that the number of endothelial cells binding apoptotic bodies gradually increased from low to high values with time. After 60 minutes of incubation, the majority of apoptotic bodies were seen inside phagosomes and only a few remained at the cell surface. Liver endothelial cells bound and endocytosed apoptotic bodies through carbohydrate-specific receptors. Moreover, this scavenger action was interleukin-1 enhanced, thus suggesting its possible activation during inflammatory and immune processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622623     DOI: 10.1242/jcs.108.3.967

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  36 in total

Review 1.  Clearance: the last and often forgotten stage of apoptosis.

Authors:  V A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 2.  Do inflammatory cells participate in mammary gland involution?

Authors:  Jenifer Monks; F Jon Geske; Lisa Lehman; Valerie A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 3.  Roles of the innate immune system in mammary gland remodeling during involution.

Authors:  Kamran Atabai; Dean Sheppard; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

4.  Phagocytic clearance of apoptotic cells: role in lung disease.

Authors:  Jeong H Yun; Peter M Henson; Rubin M Tuder
Journal:  Expert Rev Respir Med       Date:  2008-12       Impact factor: 3.772

Review 5.  The consequences of apoptosis in autoimmunity.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

Review 6.  Recognition of apoptotic cells by phagocytes.

Authors:  S P Hart; C Haslett; I Dransfield
Journal:  Experientia       Date:  1996-10-31

Review 7.  Apoptosis in cardiovascular disease.

Authors:  M J Davies
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

8.  A novel flow cytometric method for quantifying phagocytosis of apoptotic cells.

Authors:  K L Hess; G F Babcock; D S Askew; J M Cook-Mills
Journal:  Cytometry       Date:  1997-02-01

Review 9.  Innate cellular immunity and xenotransplantation.

Authors:  Hui Wang; Yong-Guang Yang
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

10.  Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient mice.

Authors:  Shana R Dalton; Serene M L Lee; Rachel N King; Amin A Nanji; Kusum K Kharbanda; Carol A Casey; Benita L McVicker
Journal:  Biochem Pharmacol       Date:  2009-01-13       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.